IMMUCELL CORP /DE/ - COM PAR (ICCC)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM PAR
Number of holders
29
Total 13F shares, excl. options
1,034,670
Shares change
-23,582
Total reported value, excl. options
$5,470,524
Value change
-$111,705
Number of buys
9
Number of sells
-14
Price
$5.34

Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2023

34 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2023.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,034,670 shares .
Largest 10 shareholders include VANGUARD GROUP INC (205,097 shares), RENAISSANCE TECHNOLOGIES LLC (121,380 shares), Cresset Asset Management, LLC (103,606 shares), Bleichroeder LP (101,594 shares), MORGAN STANLEY (87,874 shares), SHUFRO ROSE & CO LLC (62,408 shares), DIMENSIONAL FUND ADVISORS LP (57,594 shares), GEODE CAPITAL MANAGEMENT, LLC (53,213 shares), OVERBROOK MANAGEMENT CORP (32,857 shares), and Strategic Financial Services, Inc, (31,000 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.